-
Diagnostics World News Brief | Ontera and QuantuMDx announced a collaboration this week to create a next-generation solution for blood stream infection and drug resistance detection. The technology will be based on QuantuMDx’s rapid cell/sample preparation technology, Capture-XT, and Ontera’s powerful nanopore biosensor, currently used in their SAM and DUO Nano platforms.
Dec 12, 2019
-
Diagnostics World News Brief | Charles River announced that it has entered into an exclusive Discovery and Safety Services partnership with Bit Bio, a company that offers consistent and efficient reprogramming of human cells for use in research, drug discovery, and cell therapies.
Dec 11, 2019
-
Diagnostics World News | Most patients, as well as most primary care physicians, consider lung cancer to be highly lethal. That’s because early-stage disease tends to be discovered by accident rather than intentionally through screening, leading Lahey Hospital & Medical Center to develop a high-volume CT lung cancer screening program, which is scanning about 65% of the eligible population with impressive results.
Dec 9, 2019
-
Diagnostics World News | Sight Diagnostics' AI-based blood diagnostics device—called OLO—recently received 510(k) clearance for the US Food and Drug Administration (FDA), allowing the device to be marketed and sold in the US.
Dec 6, 2019
-
Diagnostics World News | Veracyte announced today that it has executed a definitive agreement with NanoString for the exclusive global license to the nCounter platform for diagnostic use as well as other tests for $40 million in cash and $10 million in stock.
Dec 3, 2019
-
Diagnostics World News | November featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Proscia, Vela, Certara, and more.
Nov 27, 2019